Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Barinthus Biotherapeutics (BRNS) Deferred Taxes (2021 - 2026)

Barinthus Biotherapeutics (BRNS) has disclosed Deferred Taxes for 6 consecutive years, with -$16000.0 as the latest value for Q1 2026.

  • For Q1 2026, Deferred Taxes rose 27.27% year-over-year to -$16000.0; the TTM value through Mar 2026 reached -$169000.0, down 482.76%, while the annual FY2025 figure was -$175000.0, 297.73% down from the prior year.
  • Deferred Taxes hit -$16000.0 in Q1 2026 for Barinthus Biotherapeutics, up from -$57000.0 in the prior quarter.
  • Across five years, Deferred Taxes topped out at $3000.0 in Q4 2024 and bottomed at -$1.9 million in Q4 2022.
  • Average Deferred Taxes over 5 years is -$449823.5, with a median of -$71000.0 recorded in 2025.
  • Year-over-year, Deferred Taxes crashed 12971.43% in 2022 and then surged 100.37% in 2024.
  • Barinthus Biotherapeutics' Deferred Taxes stood at -$1.9 million in 2022, then surged by 57.55% to -$821000.0 in 2023, then soared by 100.37% to $3000.0 in 2024, then tumbled by 2000.0% to -$57000.0 in 2025, then surged by 71.93% to -$16000.0 in 2026.
  • According to Business Quant data, Deferred Taxes over the past three periods came in at -$16000.0, -$57000.0, and -$71000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.